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Alma Ata and primary healthcare: back to the future
After 40 years, global health is returning to the vision of the Alma Ata declaration
Zulfiqar A Bhutta professor 1  2, Rifat Atun professor of global health systems 3, Navjoyt Ladher head
of scholarly comment 4, Kamran Abbasi executive editor 4
1Centre of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan ; 2Dalla Lana School of Public Health, University of
Toronto, Toronto, Canada; 3Harvard University, Boston, MA, USA; 4The BMJ, London, UK
In 1978, when the world looked different geopolitically, the
Soviet Union hosted a landmark international conference on
primary healthcare. Organised by the World Health Organization
and Unicef, the conference took place at Alma Ata (now Almaty)
and considered the role of primary healthcare in population
health. It finished with a declaration that promised “health for
all by the year 2000.”1
The Alma Ata declaration was signed by 134 countries and 67
international organisations and was groundbreaking in several
ways. The declaration promoted a holistic definition of health
“as a state of complete physical, mental and social wellbeing,
and not merely the absence of disease or infirmity.” The 10
statements of the Alma Ata declaration stressed the large
inequality in health and its social determinants and recognised
primary healthcare as integral to achieving health for all by
2000.
The conference and declaration also espoused three important
principles. Firstly, primary healthcare is an integral part and
central function of health systems. Secondly, it is essential to
social and economic development. Thirdly, primary healthcare
must be universally accessible through full community
participation and based on practical, scientifically sound, and
socially acceptable methods and technologies.1
Although the response to the declaration was generally
enthusiastic, its implementation met with many challenges. For
some countries, the model of primary healthcare proposed was
“poor care for poor people, a second-rate solution for developing
countries.”1 Others had fundamental misgivings about the
principles of universality and social justice championed by the
declaration, which they thought seemed impractical and smacked
of radicalism.1
Indeed, the declaration lacked a pragmatic plan to translate its
laudable goals into meaningful actions and results. Within a
year of the declaration, a conference hosted by the Rockefeller
Foundation in Bellagio, Italy, debated universal versus selective
approaches and recommended interim measures of selective
primary healthcare, focusing on a narrow set of high impact and
cost effective strategies to tackle major causes of death and ill
health.2 3 The outcome was a package for reducing child
mortality based on growth monitoring, oral rehydration,
breastfeeding, and immunisations (GOBI). Once expanded to
include food supplementation, female literacy, and family
planning, GOBI-FFF became a rallying cry for Unicef and other
agencies for more than a decade.
Hence, although some countries in Latin America—notably
Brazil, Cuba, and Nicaragua—introduced a new model of
comprehensive primary healthcare inspired by the Alma Ata
declaration,1 the vision lost momentum in most countries.
Instead, a more selective version of primary healthcare gained
prominence—a vertical or disease specific approach proposed
by some development agencies, notably USAID, and supported
by development economists at the World Bank.
Implementation of robust primary healthcare strategies was
hindered by a view that the burden of disease in less developed
nations was socially and economically sustained, requiring
political will to tackle social determinants.4 Another alternative
to primary healthcare was to focus on technological solutions
to reduce poverty and improve living conditions.5
Despite the competing claims of selective and comprehensive
approaches,4 most settings had ample scope for both strategies
to coexist and deliver integrated care.1 Some countries
implemented these combined strategies successfully with a
“diagonal” progression of healthcare.6 Nonetheless, the
millennium development goals reinforced the argument for
selective programmes as the best approach to reducing maternal
and child mortality. The Global Fund to Fight AIDS,
Tuberculosis, and Malaria, Gavi (the vaccine alliance), and the
President’s Emergency Fund for AIDS Relief (PEPFAR)
continued this trend by financing global initiatives targeting
large scale immunisation programmes, HIV, tuberculosis, and
malaria diagnosis and treatment.7
While these selective and vertical efforts were intended to create
positive synergies to strengthen health systems,1 and the
principles of equity and gender equality were picked up early,
they did not extend beyond their target conditions—for example,
by mobilising community health workers8 or financial support
Correspondence to: Z A Bhutta zulfiqar.bhutta@aku.edu
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2018;363:k4433 doi: 10.1136/bmj.k4433 (Published 22 October 2018) Page 1 of 2
Editorials
EDITORIALS
 o
n
 16 January 2019 by guest. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.k4433 on 22 October 2018. Downloaded from 
mechanisms.9 The conclusion from the experience of the
millennium development goals was that targeted programmes
alone were not enough. Countries needed universal health
coverage as now envisaged by the sustainable development
goals: strong health systems, underpinned by comprehensive
primary healthcare and multisectoral approaches to reduce
inequalities and ill health.1
Much has changed since the Alma Ata declaration, although
the world is still grappling with socioeconomic disparities, health
inequalities, and preventable deaths.10 Alma Ata’s vision of
health for all by 2000 proved to be a mirage. Yet hope remains
alive. The principles are as fresh and relevant today as they were
40 years ago. A renewed commitment by WHO and the United
Nations to universal health coverage means that decades after
its introduction, the approach championed by the Alma Ata
declaration remains an enlightened and forward thinking
blueprint for countries striving to achieve health for all.
In support of these principles and to further the debate, The BMJ
is creating a special collection of content on the progress and
future of primary healthcare (www.bmj.com/primaryhealthcare).
We will add relevant articles and multimedia as we publish
them.
At its 40th anniversary, revived by the impetus of the sustainable
development goals and universal health coverage, the principles
of Alma Ata must be translated into firm actions to achieve
equitable health, wellbeing, and sustainable development for
generations to come.
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